For companies/non-profit organisations
You or your company want to set up a Research & Development collaboration with one of the knowledge institutes? Do you want to get in touch with a particular researcher or research team? IXA offers a single point of entry for engaging with all Amsterdam applied and academic research. We are the intermediary for the Amsterdam research landscape, connecting you to the researchers and facilities of Amsterdam UMC, Amsterdam University of Applied Sciences (HvA), University of Amsterdam (UvA), and Vrije Universiteit Amsterdam (VU).
You can contact us with questions such as:
- How can I get in touch with an research expert in my field?
- Can you help me find a solution to a specific R&D problem?
- Can I use research facilities of one of the universities?
- Can I invest in a certain spin-off company?
Get in contact with one of our business developers. They have expertise across all research domains, helping you connect with the right people quickly and efficiently. At IXA we strongly believe in building effective and mutually beneficial partnerships, based on a personal and tailor-made approach. Each organization, each contact and each question is unique and should to be treated as such. We can help to strengthen your innovative power.
Alumni Joint Master Entrepreneurship (UvA/VU) often pursue entrepreneurial careers
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]
News
Intravacc to in-license CimCure’s iBoost technology, expanding its vaccine platform portfolio
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]
News
2016 AMSIA winner receives CE Mark for non-radioactive tumor localization system
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]
News